Prediction and interpretation of the lipophilicity of small peptides

Peptide-based drug discovery has considerably expanded and solid in silico tools for the prediction of physico-chemical properties of peptides are urgently needed. In this work we tested some combinations of descriptors/algorithms to find the best model to predict $$\log D_{\text {oct}}$$logDoct of a series of peptides. To do that we evaluate the models statistical performances but also their skills in providing a reliable deconvolution of the balance of intermolecular forces governing the partitioning phenomenon. Results prove that a PLS model based on VolSurf+ descriptors is the best tool to predict $$\log D_{\text {oct}}$$logDoct of neutral and ionised peptides. The mechanistic interpretation also reveals that the inclusion in the chemical structure of a HBD group is more efficient in decreasing lipophilicity than the inclusion of a HBA group.

[1]  P Buchwald,et al.  Octanol-water partition: searching for predictive models. , 1998, Current medicinal chemistry.

[2]  Fabrizio Giordanetto,et al.  Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. , 2014, Chemistry & biology.

[3]  Giulia Caron,et al.  A comparison of calculated and experimental parameters as sources of structural information: the case of lipophilicity-related descriptors. , 2003, Mini reviews in medicinal chemistry.

[4]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[5]  Peter Filzmoser,et al.  Multivariate linear QSPR/QSAR models: Rigorous evaluation of variable selection for PLS , 2013, Computational and structural biotechnology journal.

[6]  J. Johansson,et al.  In vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation. , 2010, Bioorganic & medicinal chemistry.

[7]  Stefano Moro,et al.  Pharmaceutical Perspectives of Nonlinear QSAR Strategies , 2010, J. Chem. Inf. Model..

[8]  Roman Rosipal,et al.  Overview and Recent Advances in Partial Least Squares , 2005, SLSFS.

[9]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[10]  I. Talavera,et al.  Critical comparative analysis, validation and interpretation of SVM and PLS regression models in a QSAR study on HIV-1 protease inhibitors , 2009 .

[11]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[12]  Luhua Lai,et al.  Calculating Partition Coefficients of Peptides by the Addition Method , 1999 .

[13]  Pierre Tufféry,et al.  PEP-FOLD: an online resource for de novo peptide structure prediction , 2009, Nucleic Acids Res..

[14]  M. Khrestchatisky,et al.  Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.

[15]  F. Milletti,et al.  Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.

[16]  Matthew P. Jacobson,et al.  Predicting and improving the membrane permeability of peptidic small molecules. , 2012, Journal of medicinal chemistry.

[17]  J. J. Nestor,et al.  The medicinal chemistry of peptides. , 2009, Current medicinal chemistry.

[18]  Joseph E Cavanaugh,et al.  Water-solvent partition coefficients and Delta Log P values as predictors for blood-brain distribution; application of the Akaike information criterion. , 2010, Journal of Pharmacy and Science.

[19]  S. Wold,et al.  PLS-regression: a basic tool of chemometrics , 2001 .

[20]  T. Fujita,et al.  Hydrophobicity of Di‐ and Tripeptides Having Unionizable Side Chains and Correlation with Substituent and Structural Parameters , 1989 .

[21]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[22]  Kurt Hornik,et al.  Misc Functions of the Department of Statistics (e1071), TU Wien , 2014 .

[23]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[24]  Shigeo Abe Support Vector Machines for Pattern Classification , 2010, Advances in Pattern Recognition.

[25]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[26]  Jianhua Yao,et al.  SVM approach for predicting LogP , 2006, Molecular Diversity.

[27]  Alexander J. Smola,et al.  Learning with kernels , 1998 .

[28]  Hadar Benyamini,et al.  Using peptides to study protein-protein interactions. , 2010, Future medicinal chemistry.

[29]  D. Craik,et al.  The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.

[30]  R. Mannhold,et al.  Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.

[31]  Horst Kessler,et al.  Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation , 2010, Anti-cancer agents in medicinal chemistry.